N.C. reimbursement law to benefit Impedimed

Device firm Impedimed is expected to benefit from the North Carolina regulation that starting Jan. 1 would require health insurers to pay physicians who screen breast cancer patients for lymphoedema. Impedimed manufactures L-Dex system, which is the only device cleared by the FDA for use in early detection of the condition.

View Full Article in:

Herald Sun (Melbourne, Australia) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID